Croda Pharma

You might be familiar with the term carbon footprint in your day-to-day life… But how does it play a role in the journey of an excipient or pharmaceutical formulation?  A Product Carbon Footprint (PCF) is the total of the greenhouse gas emissions (not just carbon!) produced and consumed over the lifecycle of the product, from raw material extraction, through manufacturing, transportation, usage, and disposal.  To determine the footprint of a product, the emissions associated with all the materials and process behind it must first be well understood! To learn more about decarbonisation and PCFs, visit:  https://ow.ly/wVTR50SEkcG

Today we announce the establishment of a new cross-industry consortium to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation. The consortium comprises Croda, ikarovec , UCL's department of Biochemical Engineering, and the Cell and Gene Therapy Catapult (CGT Catapult).   Initial scoping of the consortium was conducted by the CGT Catapult, which included interviews with key opinion leaders and a stakeholder workshop, revealing AAV formulation and stability characterisation as an important, underdeveloped area of unmet need.   The project has received funding from Innovate UK, through its Transforming Medicines Manufacturing Programme   Learn more: https://lnkd.in/dsk6TNtB   #transformingmedicinesmanufacturing #advancedtherapies #AAV #genetherapy

Explore our glass bottles offering… If you’re looking to source your high purity polysorbates in smaller volume glass bottles, register your interest here!   https://lnkd.in/eSu8WtWy

As part of our promise to empower biologics delivery, we are collaborating to develop new solutions. Our newest collaboration aims to optimise AAV formulations, in partnership with Ikaravec, UCL and The Cell and Gene Therapy Catapult!  This cross-industry consortium has been established to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation. This includes excipient selection and analytical technologies in a range of serotypes. AAV’s are the most popular gene delivery system in patient clinical trials. They are being developed to treat a broad range of inherited and chronic diseases and several AAV-based gene therapy drugs have already been approved for clinical use. If you would like to learn more about the collaboration and how we can support you, please contact alex.kramer@croda.com Learn more here https://ow.ly/nx6e50SyXRr

Our Avanti range of DSPE-PEG (2000) Maleimide enhances drug delivery efficacy as a ligand-mediated targeting agent. Beyond the typical functions of PEG lipids in stabilizing and prolonging the life span of lipid nanoparticles, the maleimide group significantly mitigates off-target effects. Discover our research grade DSPE-PEG(2000) Maleimide https://ow.ly/qsuW50Sy31l

Introducing Tween™ 20 HP LSA… Saturated free fatty acids have been associated with the formation of visible and sub-visible particles in cases where hydrolytic degradation of polysorbate 20 occurs. Tween™ 20 HP LSA is a highly purified polysorbate 20 that has been designed to provide functional equivalence as a surfactant whilst reducing the associated risk of visible and sub-visible particle formation in protein formulations. This has been achieved through a very highly controlled fatty acid distribution with lower content of long chain saturated fatty acids. Want to learn more? Download our datasheet or request for a free sample here: https://lnkd.in/e4nFaURD

Explore the evolution of vaccine adjuvants, from its discovery in 1920 to today’s innovative solutions. Learn how adjuvants enhance immune responses and drive vaccine efficacy, ensuring better protection with fewer doses. Read now! #CrodaPharma #EmpoweringBiologicsDelivery #VaccineAdjuvants #PharmaInsights

Explore the evolution of vaccine adjuvants, from its discovery in 1920 to today’s innovative solutions. Learn how adjuvants enhance immune responses and drive vaccine efficacy, ensuring better protection with fewer doses. Read now! #CrodaPharma #EmpoweringBiologicsDelivery #VaccineAdjuvants #PharmaInsights

Dive into the benefits of Virodex™: sustainable, superior substitutes to Triton™ X-100. Watch our expert, Dr. Kritika Bajaj, present on how Virodex™ addresses the industry’s need to find a suitable replacement for your downstream bioprocessing needs.  Download our technical poster and view our presentation!  https://ow.ly/qair50Sr9MI

Dive into the benefits of Virodex™: sustainable, superior substitutes to Triton™ X-100. Watch our expert, Dr. Kritika Bajaj, present on how Virodex™ addresses the industry’s need to find a suitable replacement for your downstream bioprocessing needs.  Download our technical poster and view our presentation!  https://ow.ly/qair50Sr9MI